The outlook of companies tied to blockbuster drugs like Viagra presents a complex investment scenario . While the initial surge of copyright, fueled by Viagra's unprecedented popularity, generated substantial returns, the loss of exclusivity in key markets has introduced substantial uncertainty . Investors are now grappling with the consequences of